Castleark Management LLC Invests $11.54 Million in HealthEquity, Inc. $HQY

Castleark Management LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 127,770 shares of the company’s stock, valued at approximately $11,540,000. Castleark Management LLC owned 0.15% of HealthEquity at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Acumen Wealth Advisors LLC purchased a new position in HealthEquity during the 4th quarter worth $27,000. Caitong International Asset Management Co. Ltd boosted its holdings in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of HealthEquity in the fourth quarter valued at about $28,000. Leonteq Securities AG increased its stake in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after acquiring an additional 235 shares during the period. Finally, Axiom Investment Management LLC acquired a new position in shares of HealthEquity during the first quarter worth about $33,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HQY has been the subject of several analyst reports. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday. Royal Bank Of Canada boosted their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. BTIG Research raised their price target on HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a report on Friday, July 24th. Finally, Barrington Research restated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Eleven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $110.93.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This trade represents a 7.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock worth $1,651,280 in the last quarter. Company insiders own 1.60% of the company’s stock.

HealthEquity Stock Down 0.0%

HQY stock opened at $105.39 on Wednesday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company’s 50-day moving average price is $97.41 and its 200 day moving average price is $87.53. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $107.62. The company has a market cap of $8.81 billion, a P/E ratio of 39.47, a P/E/G ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.